Summary
University of Maryland (UMD) is a research university that operates with colleges and schools. The university offers academic departments and programs include agricultural and resource economics, American studies, animal and avian sciences, anthropology, applied mathematics and scientific computation program, Arabic studies, behavioral and community health, biochemistry, bioengineering, and chemical physics program, among others. It provides services to college of agriculture and natural resources, school of architecture, planning, and preservation, college of arts and humanities, college of behavioral and social sciences, robert h. smith school of business, college of computer, and college of education among others. UMD is headquartered in College Park, Maryland, the US.
University of Maryland - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
University of Maryland, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
University of Maryland, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
University of Maryland, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
University of Maryland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
University of Maryland, Medical Devices Deals, 2010 to YTD 2016 9
University of Maryland, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
University of Maryland, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
University of Maryland Enters Into Licensing Agreement With Harpoon Medical 12
ImmunoCellular Therapeutics Enters into Research Agreement with University of Maryland, Baltimore 13
Nosocomial Vaccine Enters into Agreement with Affinivax and University of Maryland 14
University Of Maryland School Of Medicine Enters Into Co-Development Agreement With MRIGlobal Dx 15
University of Maryland School of Medicine Forms Joint Venture With Advanced Particle Therapy 16
Licensing Agreements 18
Educational and Scientific Enters into Licensing Agreement with University of Maryland 18
Tokai Pharma Amends Licensing Agreement with University of Maryland, Baltimore 19
Rexahn Pharma Enters Into Licensing Agreement With University of Maryland For Nano-Polymer-Drug Conjugate Systems 20
SilcsBio Enters Into Licensing Agreement With UM Ventures 21
Tokai Pharma Amends Licensing Agreement with University of Maryland, Baltimore 22
University Of Maryland Enters Into Licensing Agreement With Bali BioSciences 23
Sirnaomics Enters Into Licensing Agreement With University of Maryland Medical School 24
Asset Transactions 25
Prolias Acquires Antibody Technology From University of Maryland Biotech Institute 25
Acquisition 26
AE Biofuels Acquires Zymetis 26
University of Maryland - Key Competitors 28
Key Employees 29
Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32
List of Tables
University of Maryland, Pharmaceuticals & Healthcare, Key Facts 1
University of Maryland, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
University of Maryland, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
University of Maryland, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
University of Maryland, Deals By Therapy Area, 2010 to YTD 2016 8
University of Maryland, Medical Devices Deals, 2010 to YTD 2016 9
University of Maryland, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
University of Maryland Enters Into Licensing Agreement With Harpoon Medical 12
ImmunoCellular Therapeutics Enters into Research Agreement with University of Maryland, Baltimore 13
Nosocomial Vaccine Enters into Agreement with Affinivax and University of Maryland 14
University Of Maryland School Of Medicine Enters Into Co-Development Agreement With MRIGlobal Dx 15
University of Maryland School of Medicine Forms Joint Venture With Advanced Particle Therapy 16
Educational and Scientific Enters into Licensing Agreement with University of Maryland 18
Tokai Pharma Amends Licensing Agreement with University of Maryland, Baltimore 19
Rexahn Pharma Enters Into Licensing Agreement With University of Maryland For Nano-Polymer-Drug Conjugate Systems 20
SilcsBio Enters Into Licensing Agreement With UM Ventures 21
Tokai Pharma Amends Licensing Agreement with University of Maryland, Baltimore 22
University Of Maryland Enters Into Licensing Agreement With Bali BioSciences 23
Sirnaomics Enters Into Licensing Agreement With University of Maryland Medical School 24
Prolias Acquires Antibody Technology From University of Maryland Biotech Institute 25
AE Biofuels Acquires Zymetis 26
University of Maryland, Key Competitors 28
University of Maryland, Key Employees 29
University of Maryland, Subsidiaries 30
List of Figures
University of Maryland, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
University of Maryland, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
University of Maryland, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
University of Maryland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
University of Maryland, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
University of Maryland, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
University of Maryland, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
University of Maryland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
University of Maryland, Medical Devices Deals, 2010 to YTD 2016 9
